See the below link of a news story from today about new federal grant money of up to $5 million each now available for small biotech firms.
From the news story link below:
"The funds discussed Friday will be awarded on a selective basis to firms that show promise in developing cost-saving therapies, generating or sustaining high-paying jobs, and increasing U.S. competitiveness."
It sure appears Guided Therapeutics would be a good candidate to obtain this funding. Obtaining this funding is a good potential piece of news, as this is a huge issue to get their cervical cancer product into production. Enjoy your weekend. Here's the link:
Great Find.. I would say we fit into the category to get Funding.. It would be pretty Big News.. It would show the acceptance of our Technology. And Any Cash Company can get without Dilution is good for us as Shareholders of course.. GLTA..
I do think they'll get the grant money. In the article they mention cancer as being a focus area for the money. Also, keep in mind, Guided Therapeutics has shown the consistent ability to navigate the (I'm sure complicated) process of applying and receiving public funds (i.e- NCI / Georgia Research Alliance). I'm certain you must dot your "I" and cross your "T" to get the money. We are fortunate that GTHP is this type of company. Paperwork, and proper controls are so important to work within the medical field. Startups may struggle with this, but remember Guided Therapeutics has been there before. Experience does matter and as a matter of fact if look at the key people at GTHP, you'll see they actually have done reviews for the the NIH.
Anyway, thanks for the response.
It is a little discouraging to see the share price where it is, but as long term holder, I just ignore this as noise in a much bigger picture to unfold. The key is to keep assembling little pieces of the puzzle and that is what good due diligence can do. I do think you and I follow the same philosophy.
The shareholders meeting is coming up this week. If anyone goes, please report back on the meeting. I'd love it hear about it, since I can't attend.